PHAR vs BIIB: Which Stock is Better?
Side-by-side comparison of Pharming Group NV and Biogen Inc in 2026
PHAR
Pharming Group NV
—
BIIB
Biogen Inc
$208.92
Key Metrics Comparison
| Metric | PHAR | BIIB | Winner |
|---|---|---|---|
| Market Cap | $723.60M | $29.33B | BIIB |
| P/E Ratio | N/A | 21.39 | BIIB |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHAR
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAR or BIIB a better investment?
Comparing PHAR and BIIB: Pharming Group NV has a market cap of $723.60M while Biogen Inc has $29.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAR and BIIB?
PHAR (Pharming Group NV) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAR or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAR or BIIB?
Both PHAR and BIIB show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHAR or BIIB?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHAR or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $29.33B compared to $723.60M for PHAR.
Should I buy PHAR or BIIB in 2026?
Both PHAR and BIIB have investment merit. PHAR trades at $N/A while BIIB trades at $208.92. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAR and BIIB stock?
Key differences: Market Cap ($723.60M vs $29.33B), P/E Ratio (N/A vs 21.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHAR or BIIB in 2026?
The choice between PHAR and BIIB depends on your investment goals. BIIB shows higher revenue growth (0.0%). BIIB has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHAR and BIIB?
PHAR (Pharming Group NV) has a market cap of $723.60M, while BIIB (Biogen Inc) has a market cap of $29.33B. BIIB is the larger company by market value.